IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Venrock Adviser, LLC

Q3 2021 Holdings

Filed 2021-11-15 | 26 holdings | $294.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$82.2M4,563,96227.9%
Celldex Therapeutics Inc(CLDX)COM15117B202$59.3M1,098,17420.1%
Aadi Bioscience Inc(WHWK)COM00032Q104$44.9M1,529,40215.3%
Altimmune Inc(ALT)COM02155H200$43.0M3,800,00014.6%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$16.6M3,427,4615.6%
Cullinan Oncology Inc(CGEM)COM230031106$15.9M706,0505.4%
Atyr Pharma Inc(ATYR)COM002120202$14.2M1,565,0004.8%
Cogent Biosciences Inc(COGT)COM19240Q201$9.2M1,088,8173.1%
Cvrx Inc(CVRX)COM126638105$8.8M533,3703.0%
Instil BIO IncCOM45783C101$122.7K6,865,0760.0%
Vistagen Therapeutics Inc(VTGNUSD)COM92840H202$44.0K16,047,2860.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$42.3K1,536,1930.0%
Travere Therapeutics Inc(TVTX)COM89422G107$42.0K1,732,4100.0%
Relmada Therapeutics Inc(RLMD)COM75955J402$36.4K1,387,7200.0%
GH Research PLC(GHRS)ORD SHG3855L106$36.2K1,642,2960.0%
Kinnate Biopharma IncCOM49705R105$33.9K1,473,0140.0%
Marinus Pharmaceuticals Inc(MRNS*)COM56854Q200$30.1K2,641,8090.0%
Graphite BIO Inc(GRPH)COM38870X104$26.4K1,612,6170.0%
Centessa Pharmaceuticals PLC(CNTA)SPONS ADR152309100$18.8K1,127,2720.0%
Nuvalent Inc(NUVL)COM670703107$18.1K803,9510.0%
Athira Pharma IncCOM04746L104$11.2K1,196,1960.0%
Pharvaris NV(PHVS)COMN69605108$9.8K552,8820.0%
Akoya Biosciences IncCOM00974H104$5.6K400,0000.0%
Astria Therapeutics Inc(CATBUSD)COM04635X102$4.8K538,9990.0%
Tricida Inc(1T7)COM89610F101$1.8K390,7070.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$32119,4950.0%